Navigation Links
GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
Date:10/30/2008

PHILADELPHIA, Oct. 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today issued the following response to a petition filed by Public Citizen to the U.S. Food and Drug Administration (FDA) on AVANDIA(R) (rosiglitazone maleate), a highly effective therapy for treating type 2 diabetes when used in the appropriate patient population.

The safety of patients using our medicine is very important to us. On a continual basis, an external Hepatic Safety Board reviews any adverse event report received by GSK of liver failure, liver-related deaths and liver transplants for possible relationship to AVANDIA. As recently as July 2008, this panel of experts continued to endorse a favorable hepatic safety profile for AVANDIA.

Patients being treated with AVANDIA or other medicines to control blood sugar levels should remain on therapy, unless their doctor advises a different course of action.

AVANDIA has been shown to be a safe and highly effective treatment for type 2 diabetes for the appropriate patient. GSK strongly supports the safety and efficacy of AVANDIA based on extensive clinical trial experience and widespread post-marketing use. The record of safety and effectiveness of AVANDIA is backed by one of the largest clinical trial programs (including 52,000 patients) ever undertaken for any medicine.

Data from long-term clinical trials, which offer the most rigorous scientific measurement of safety and efficacy, provide substantial evidence to assess the benefit-risk of AVANDIA in treating patients with diabetes. Importantly, the Public Citizen petition did not include data from the current Prescribing Information for AVANDIA regarding ADOPT (A Diabetes Outcomes Progression Trial). ADOPT, the largest head-to-head diabetes trial, showed that AVANDIA sustained glycemic control longer than metformin or sulfonylurea, for up to five years. Additionally, outcomes from five long-term clinical studies did not demonstrate an increased risk of t
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
2. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
3. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
4. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
5. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
6. New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
7. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
8. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
9. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
10. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
11. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
(Date:5/23/2013)... CHINA , May 24, 2013 ... or the "Company"), a leading China ... manufacturing and marketing biopharmaceutical products, announced today that, ... "EGM"), the Company,s shareholders voted in favor of ... announced agreement and plan of merger dated February ...
(Date:5/23/2013)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... Chief Executive Officer of Neurocrine Biosciences, will be presenting at ... Conference in Boston.   The live presentation takes ... / 8:20 a.m. Pacific Time.  The presentation will be webcast ... http://www.neurocrine.com . If you are unable to ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 33SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... N.Y., Feb. 21, 2012  Regeneron Pharmaceuticals, Inc. (Nasdaq: ... following investor conferences: , Citi 2012 Global Healthcare ... 28, 2012 , RBC Capital Markets, Healthcare Conference ... 2012 The sessions may be accessed through ...
... PHILADELPHIA, Pennsylvania and WALTHAM, Massachusetts, February 21, 2012 ... clinical decision support content and analytics tools into ... Elsevier , a world-leading provider of scientific, ... PatientKeeper ®, the leading provider of physician ...
Cached Medicine Technology:Regeneron Announces February 2012 Investor Conference Presentations 2Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE 2Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE 3Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE 4
(Date:5/24/2013)... York (PRWEB) May 24, 2013 ... DePuy hip recall continue to move forward in courts ... to documents filed in California’s San Francisco Superior Court ... an expedited trial of her DePuy hip lawsuit is ... DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. Super. ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 ResortQuest Real ... joined the Dayna Feher team at the firm’s Bethany ... the Delaware resorts her home in 1975. Her real ... worked in all aspects of the real estate business ... the past 12 years, a licensed sales associate. ...
(Date:5/24/2013)... News) -- New research suggests a link between ... insomnia. Every additional hour someone with insomnia ... in the likelihood of moderate or high risk ... of Pennsylvania. "We were surprised by ... and suicide risk," study author, Linden Oliver, clinical ...
(Date:5/24/2013)... used to treat glaucoma may cause droopy eyelids and ... to a new study. The drugs, known as ... pressure, have already been shown to cause blurred vision, ... suggesting that the new findings could lead to labeling ... when prescribing these drugs, the researchers added, particularly as ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... the U.S. Food and Drug Administration,s (FDA) recent decision ... front-line treatment of non-Hodgkin,s lymphoma (NHL). ... said Michael M. Graham, M.D., Ph.D., president of SNM ... Iowa Carver College of Medicine. "We,ve known for some ...
... ... battling heath care red tape and now directs her brother,s story to the White House ... Los Angeles, CA (PRWeb) ... anchor Veronica De La Cruz brought the tale of her brother Eric,s tragic battle against ...
... , , , ... The Florida Hospital Association (FHA) and the South Florida Hospital ... ECRI Institute Patient Safety Organization (PSO) to support the Patient ... and analysis. PSOFlorida, a component organization of the FHA and ...
... , Members Take to the Streets to Debunk Health ... to Congress , , CHICAGO, Sept. ... with Congress back to work in Washington, AARP members converged on downtown Chicago ... right. , , With a giant inflatable prescription ...
... BOULDER, Colo., Sept. 10 Culinary Software Services, ... industry, announces the addition of Allergen Alerts to its ... Consumer Protection Act, the FDA requires food labels to clearly ... major allergenic foods. Labels are required to identify the ...
... , , WASHINGTON, Sept. ... in natural and organic foods, and Chef Ann Cooper, the nation,s "renegade ... country by kicking off the "School Lunch Revolution" awareness tour today in ... Co-President and Chief Operating Officer Walter Robb will speak to key influencers ...
Cached Medicine News:Health News:SNM applauds FDA's decision to approve Zevalin 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 3Health News:Patient Safety Organization of Florida Teams With ECRI Institute PSO for Patient Safety Reporting and Analysis 2Health News:Patient Safety Organization of Florida Teams With ECRI Institute PSO for Patient Safety Reporting and Analysis 3Health News:AARP Delivers Health Care Reform 'Message in a Bottle' in Chicago 2Health News:Allergen Alerts Added to ChefTec Software for Enhanced Food Safety Functionality 2Health News:Whole Foods Market(R) Executive and Chef Ann Cooper Visit Washington, D.C. to Raise Awareness About Importance of Healthy School Lunches 2Health News:Whole Foods Market(R) Executive and Chef Ann Cooper Visit Washington, D.C. to Raise Awareness About Importance of Healthy School Lunches 3Health News:Whole Foods Market(R) Executive and Chef Ann Cooper Visit Washington, D.C. to Raise Awareness About Importance of Healthy School Lunches 4
... Diagnostics Histoplasma DxSelect is intended for qualitatively ... in human serum. The test is indicated ... disease, as an aid in the presumptive ... is not intended for self-testing, and this ...
... Indirect immunofluorescent antibody (IFA) ... and semi-quantitation of human ... Epstein-Barr viral capsid antigen ... ten 12-well slides, FITC ...
... portable, battery-powered, micro-controlled, noninvasive bone growth stimulator ... primary lumbar spinal fusion surgery for one ... been shown in pre-clinical studies to help ... Clinical studies have also shown that individuals ...
... Medical Solutions introduces its new multifunctional ... with intuitive patient data management is ... and urological table. Lithoskop is an ... that covers all applications like lithotripsy, ...
Medicine Products: